Palatin Technologies, Inc.
PTNPalatin Technologies, Inc. in brief
Palatin Technologies, Inc. is a listed company in the Biotechnology industry, based in Cranbury, New Jersey, USA. Its market value was $9 M on 30 October 2026, which makes it the 26,136th largest listed company in the world and the 4,328th largest in the USA on this site. In the year to June 2026 it had sales of $9 M and a net loss of $8 M. It employs about 25 people and Carl Spana is its chief executive. Its shares trade under the symbol PTN (Nasdaq).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About Palatin Technologies, Inc.
Palatin™ is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. Our product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin’s strategy is to develop products and then form marketing collaborations with industry leaders to maximize product commercial potential.
The MCR system has effects on inflammation and immune system response, food intake, metabolism, and sexual function. There are five melanocortin receptors, MC1R through MC5R. Modulation of these receptors, through use of receptor-specific agonists, which activate receptor function, or receptor-specific antagonists, which block receptor function, can have significant pharmacological effects. We believe that our MC1R agonist peptides have broad anti-inflammatory effects and utilize mechanisms engaged by the endogenous melanocortin system in regulation of the immune system and resolution of inflammatory responses. We are also developing peptides that are active at more than one melanocortin receptor and small molecule MCR agonists.
From the company's annual report filed with the US SEC: read the report
Palatin Technologies, Inc. timeline
- 1996
- •· approximateFirst filing with the US SECThe company's first electronic filing in SEC EDGAR.
- ✎Renamed Palatin Technologies IncFormerly Interfilm Inc.
- 1999
- 🔔· approximateInitial public offering on Nasdaq
- 2023
- 💰Record net income of $36 millionFY2023, the highest profit of the 4 years on record.
Events of Palatin Technologies, Inc. from SEC EDGAR, the company record and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in USA: #5,197 (Dec 2022) · #5,150 (Jul 2023) · #4,092 (Jan 2024) · #2,174 (Mar 2026) · #3,968 (Aug 2026) · #4,176 (Oct 2026) · #4,331 (Oct 2026)
Key ratios
- P/E ratio (TTM)
- n/m (loss)
- Price / sales (TTM)
- 1.0×
- Price / book
- 1.3×
- Free cash flow yield
- -154.7%
- Net margin (TTM)
- -94.9%
- Operating margin
- -98.2%
- Return on equity
- -125.3%
- Liabilities / assets
- 21.6%
- Net debt
- $-43M
- Revenue growth
- +96.7%
- R&D / revenue
- 140.1%
- Revenue per employee
- $353 K
- Profit per employee
- $-335 K
Financial history
| Fiscal year ending | Revenue | Growth | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| Jun 2026 | $9M | — | $-9M | $-8M | -94.9% |
| Jun 2025 | — | — | $-17M | $-17M | — |
| Jun 2024 | $4M | -7.4% | $-23M | $-30M | -662.4% |
| Jun 2023 | $5M | +229.9% | $-32M | $-24M | -495.7% |
| Jun 2022 | $1M | — | $-37M | $-36M | -2462.6% |
| Jun 2021 | — | — | $-33M | $-34M | — |
| Jun 2020 | — | — | $-24M | $-22M | — |
| Jun 2019 | $60M | — | $36M | $36M | 59.3% |
Cash flow, debt and per share
| Fiscal year ending | Operating cash flow | Capital spending | Free cash flow | EPS (diluted) | Dividend / share |
|---|---|---|---|---|---|
| Jun 2026 | $-14M | $0M | $-14M | $-2.96 | — |
| Jun 2025 | $-21M | $0M | $-21M | $-32.15 | — |
| Jun 2024 | $-31M | $0M | $-32M | $-101.16 | — |
| Jun 2023 | $-29M | $0M | $-30M | — | — |
| Jun 2022 | $-30M | $0M | $-30M | — | — |
| Jun 2021 | $-0M | $0M | $-0M | $-0.14 | — |
| Jun 2020 | $41M | $0M | $41M | $-0.10 | — |
| Jun 2019 | $-22M | $0M | $-22M | $0.16 | — |
Quarterly results
Latest quarter to Jun 2026: revenue $0M, net income $-4M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Jun 2026.
SEC filings
- Sep 28, 202610-KAnnual report · period to Jun 2026
- Aug 3, 20268-KCurrent reportShareholder vote
- Jun 25, 2026DEF 14AProxy statement
- May 18, 20268-KCurrent reportListing notice · Regulation FD disclosure
- May 13, 202610-QQuarterly report · period to Mar 2026
- Feb 17, 202610-QQuarterly report · period to Dec 2025
- Dec 19, 20258-K/ACurrent report (amended)Shareholder vote
- Nov 14, 202510-QQuarterly report · period to Sep 2025
- Nov 12, 20258-KCurrent reportOther events
- Nov 12, 2025424B4IPO prospectus
- Nov 10, 2025424B4IPO prospectus
- Nov 6, 20258-KCurrent reportMaterial agreement · Other events
Official filings of Palatin Technologies, Inc. with the US Securities and Exchange Commission.
Annual results
- Revenue
- $9 M
- Operating income
- $-9 M
- Net income
- $-8 M
For year ending June-2026 · source: SEC filing
Balance sheet
- Total assets
- $9 M
- Total liabilities
- $2 M
- Total equity
- $7 M
As of June-2026
Top 30 institutional investors in Palatin Technologies, Inc.#
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 1 | Driehaus Capital Management LLC | 166,713 | 0 (0.00%) | 9.36% | $1 M | Nov 16, 2026 |
| 2 | Janus Henderson Group Ltd. | 140,000 | — | 7.86% | $1 M | Nov 16, 2026 |
| 3 | Ikarian Capital, LLC | 130,000 | New | 7.30% | $1 M | Nov 16, 2026 |
| 4 | Logos Global Management LP | 129,260 | -740 (-0.57%) | 7.26% | $1 M | Nov 16, 2026 |
| 5 | Ra Capital Management, L.P. | 62,124 | 0 (0.00%) | 3.49% | $1 M | Nov 16, 2026 |
| 6 | Boothbay Fund Management, LLC | 38,168 | New | 2.14% | $0 M | Nov 16, 2026 |
| 7 | Balyasny Asset Management L.P. | 36,298 | -4,812 (-11.71%) | 2.04% | $0 M | Nov 16, 2026 |
| 8 | Morgan Stanley | 27,272 | 0 (0.00%) | 1.53% | $0 M | Nov 13, 2026 |
| 9 | Geode Capital Management, LLC | 20,620 | +1,238 (+6.39%) | 1.16% | $0 M | Nov 6, 2026 |
| 10 | Vanguard Capital Management LLC | 18,911 | 0 (0.00%) | 1.06% | $0 M | Nov 13, 2026 |
| 11 | Jane Street Group, LLC | 17,003 | New | 0.95% | $0 M | Nov 12, 2026 |
| 12 | Miller Financial Services LLC | 15,000 | 0 (0.00%) | 0.84% | $0 M | Oct 20, 2026 |
| 13 | LPL Financial LLC | 14,279 | +1,727 (+13.76%) | 0.80% | $0 M | Nov 6, 2026 |
| 14 | State Street Corp | 14,000 | New | 0.79% | $0 M | Nov 12, 2026 |
| 15 | Vanguard Fiduciary Trust Co | 8,842 | 0 (0.00%) | 0.50% | $0 M | Nov 13, 2026 |
| 16 | BlackRock, Inc. | 5,407 | -245 (-4.33%) | 0.30% | $0 M | Nov 13, 2026 |
| 17 | UBS Group AG | 1,675 | -1,311 (-43.90%) | 0.09% | $0 M | Nov 10, 2026 |
| 18 | Vanguard Global Advisers, LLC | 1,250 | 0 (0.00%) | 0.07% | $0 M | Nov 13, 2026 |
| 19 | Tower Research Capital LLC (TRC) | 354 | -239 (-40.30%) | 0.02% | $0 M | Nov 16, 2026 |
| 20 | Jones Financial Companies Lllp | 155 | 0 (0.00%) | 0.01% | $0 M | Nov 13, 2026 |
| 21 | US Bancorp \de\ | 125 | 0 (0.00%) | 0.01% | $0 M | Nov 5, 2026 |
| 22 | SBI Securities Co., Ltd. | 107 | 0 (0.00%) | 0.01% | $0 M | Oct 22, 2026 |
| 23 | Royal Bank Of Canada | 49 | New | 0.00% | $0 M | Nov 16, 2026 |
| 24 | Caitong International Asset Management Co., Ltd | 18 | New | 0.00% | $0 M | Oct 29, 2026 |
| 25 | West Paces Advisors Inc. | 12 | 0 (0.00%) | 0.00% | $0 M | Oct 13, 2026 |
Show all 30: investors 26 to 30
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 26 | Jpmorgan Chase & Co | 4 | New | 0.00% | $0 M | Nov 12, 2026 |
| 27 | Wells Fargo & Company/mn | 4 | 0 (0.00%) | 0.00% | $0 M | Nov 16, 2026 |
| 28 | Osaic Holdings, Inc. | 4 | -166 (-97.65%) | 0.00% | $0 M | Nov 12, 2026 |
| 29 | Barclays PLC | 1 | -9 (-90.00%) | 0.00% | $0 M | Nov 6, 2026 |
| 30 | Cassaday & Co Wealth Management LLC | 1 | New | 0.00% | $0 M | Oct 27, 2026 |
Mutual funds holding Palatin Technologies, Inc.#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc. | 18,911 | $0 M | 1.1% | <0.01% | −0.4% | Jun 30, 2026 |
| 🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC | 8,904 | $0 M | 0.50% | <0.01% | −4.3% | May 31, 2026 |
| 🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors | 5,313 | $0 M | 0.30% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC | 3,119 | $0 M | 0.18% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC | 2,621 | $0 M | 0.15% | <0.01% | +10.0% | May 31, 2026 |
| 🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC | 339 | $0 M | 0.02% | <0.01% | new | Jun 30, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jun 30, 2026. The 6 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
Insider trading at Palatin Technologies, Inc.#
Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Stephen T. WillsExecutive VP and CFO/COO | Shares withheld for tax10b5-1 plan | -22 | $11.77 | $259 | 63,965 | Form 4 |
| filed | Carl SpanaPresident and CEO, Director | Shares withheld for tax10b5-1 plan | -33 | $11.77 | $388 | 65,160 | Form 4 |
| filed | Stephen T. WillsExecutive VP and CFO/COO | Shares withheld for tax10b5-1 plan | -79 | $11.72 | $926 | 63,886 | Form 4 |
| filed | Carl SpanaPresident and CEO, Director | Shares withheld for tax10b5-1 plan | -119 | $11.72 | $1 K | 65,041 | Form 4 |
| filed | Stephen T. WillsExecutive VP and CFO/COO | Shares withheld for tax10b5-1 plan | -94 | $14.34 | $1 K | 63,792 | Form 4 |
| filed | Carl SpanaPresident and CEO, Director | Shares withheld for tax10b5-1 plan | -142 | $14.34 | $2 K | 64,899 | Form 4 |
| filed | Carl SpanaPresident and CEO, Director | Shares withheld for tax10b5-1 plan | -40 | $21.38 | — | 64,658 | Form 4 |
| filed | Stephen T. WillsExecutive VP and CFO/COO | Shares withheld for tax10b5-1 plan | -26 | $21.38 | — | 63,462 | Form 4 |
Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals
Markets and events: Palatin Technologies, Inc.#
Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.
Trading halts
- 2025-12-17 16:17 UTC, code M, resumed 16:22 UTC
- 2025-11-21 19:14 UTC, code M, resumed 19:19 UTC
- 2025-11-21 18:47 UTC, code M, resumed 18:57 UTC
- 2025-11-21 18:41 UTC, code M, resumed 18:46 UTC
- 2025-11-21 18:30 UTC, code M, resumed 18:40 UTC
Fails to deliver
- : 2,209 shares at $4.93
- : 121 shares at $5.51
- : 121 shares at $5.55
- : 121 shares at $5.52
- : 51 shares at $5.99
Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables
Palatin Technologies, Inc. scorecard#
Passes 5 of the 17 checks that could be worked out: strongest in valuation (2 of 5), weakest in profitability (1 of 5). Fiscal year 2026; market cap of Oct 30, 2026.
Valuation2 of 5
- ✗P/E below its peers' medianNo P/EThe company made a loss over the last twelve months.
- ✓Price to book below its peers' median1.3×Price to book 1.3× against Biotechnology's median of 2.9×.
- ✓Price to sales below its peers' median1.0×Price to sales 1.0× against Biotechnology's median of 8.7×.
- ✗Free cash flow yield above 5%-154.7%Free cash flow is -154.7% of the market value.
- ✗Earnings yield above the 10-year Treasury yieldLossA loss earns nothing against the 10-year Treasury's 5.15% (2026-11-13).
- –The price assumes slower growth than the last three years'Free cash flow of the last three years is missing or below zero on average.
Growth1 of 2
- –Revenue grew in the newest yearRevenue of the year before is not on file.
- –Revenue up more than 5% a year over three yearsRevenue of three years earlier is not on file.
- –Faster growth over three years than its peers' medianRevenue of three years earlier is not on file.
- ✗Earnings per share grew in the newest year-2.96 vs -32.15Diluted EPS -2.96 in fiscal 2026 against -32.15 the year before (report's currency).
- ✓Net income higher than five years earlier-$8 M-$8 M in fiscal 2026 against -$34 M in 2021.
- –Revenue rose in at least four of the last five yearsFive years of revenue changes are not on file.
Profitability1 of 5
- ✗Profitable in the newest year-$8 MNet income -$8 M in fiscal 2026.
- ✗Profitable in each of the last five years0 of 5Profitable in 0 of the five years to fiscal 2026.
- ✗Operating margin above its peers' median-98.2%-98.2% against Biotechnology's median of -60.5% (243 companies).
- ✗Return on equity above 15%-877.5%-877.5% in fiscal 2026.
- –Return on invested capital above 10%No return on invested capital on file.
- ✓Operating margin wider than three years earlier-98.2%-98.2% in fiscal 2026 against -669.3% in 2023.
Financial health1 of 4
- ✓Short-term assets cover short-term liabilities4.6×Current ratio 4.61 at the end of fiscal 2026.
- –Debt below equityDebt or equity is not on file (or equity is negative).
- –Net debt below three years of EBITDANet debt to EBITDA is not on file.
- ✗Operating income covers interest five times-867.0×Operating income -867.0 times interest in fiscal 2026.
- ✗Cash from operations positive in each of the last three years0 of 3Positive in 0 of the three years to fiscal 2026.
- ✗Altman Z-score outside the distress zone-75.37Z-score -75.37 (distress zone) for fiscal 2026.
Shareholder returns0 of 1
- –Pays a dividendDividends are not on file.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
- ✗Share count up no more than 2% in a year425.5%Diluted shares up 425.5% in fiscal 2026.
- –Dividends and buybacks above 3% of the market valueDividends and buybacks are not on file.
- –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.
Worked out from the statements as filed (sec), the medians of Biotechnology, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
Financial analysis, 2026#
Worked out from Palatin Technologies, Inc.'s statements, beside the median of Biotechnology.
| Ratio | Trend | 2026 | Median of peers |
|---|---|---|---|
| Operating margin | -98.2% | -60.5% | |
| Net margin | -94.9% | -68.9% | |
| Return on equity | -877.5% | -61.0% | |
| Free cash flow margin | -153.8% | -61.5% |
2of 6on the Piotroski tests of financial strength
- Net loss of $8 million, the 7th loss-making year in a row.
- Free cash flow was negative: -$14 million.
- The share count rose 425.5% in the year.
- Operating income covers the interest bill only -867.0 times.
Palatin Technologies, Inc.: financial statements#
Income statement, balance sheet and cash-flow statement as reported, newest period first.
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | FY 2026to Jun 30, 2026 | FY 2025to Jun 30, 2025 | FY 2024to Jun 30, 2024 | FY 2023to Jun 30, 2023 | FY 2022to Jun 30, 2022 | FY 2021to Jun 30, 2021 | FY 2020to Jun 30, 2020 | FY 2019to Jun 30, 2019 | FY 2018to Jun 30, 2018 | FY 2017to Jun 30, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||
| Revenue | 8.8—100% | 0−100%— | 4.5−7.5%100% | 4.9+231%100% | 1.5—100% | −0.2−260%— | 0.1−99.8%100% | 60−10.2%100% | 67+50.1%100% | 45—100% | |
| Cost of revenue | — | — | 0.1−76.7%2.2% | 0.4+92.4%8.6% | 0.2+47.1%14.8% | 0.1—— | 0—0.0% | — | — | — | |
| Research and development | 12−17.0%140% | 15−33.5%— | 22−1.0%499% | 23+6.1%466% | 21+65.0%1452% | 13−7.4%— | 14−6.0%11831% | 15−54.4%24.6% | 33−28.7%48.5% | 46—102% | |
| Selling, general and administrative | — | 7.8−36.4%— | 12−19.8%273% | 15−7.4%315% | 17—1124% | — | — | — | — | — | |
| General and administrative | 9.5+21.4%107% | 7.8—— | — | — | 17−4.8%1124% | 17+77.5%— | 9.8+0.7%8277% | 9.7+12.2%16.1% | 8.6−10.1%12.9% | 9.6—21.5% | |
| Operating expenses | 22+25.2%247% | 17−35.3%— | 27−27.7%601% | 37−2.0%769% | 38+14.6%2592% | 33—— | −24r24−196%−20008% | 25−40.4%40.7% | 41−25.5%61.4% | 55—124% | |
| Total costs and expenses | — | 9.20.0%— | 9.2+1.3%205% | 9.1—188% | — | — | — | — | — | — | |
| Operating income | −8.7—−98.2% | −17—— | −22—−501% | −32—−669% | −37—−2492% | −33—— | −24−166%−20008% | 36+37.9%59.3% | 26—38.6% | −11—−23.6% | |
| Interest and finance income | — | — | — | — | — | 0.0−98.0%— | 1.2+169%1018% | 0.4+43.7%0.7% | 0.3+1083%0.5% | 0.0—0.1% | |
| Interest expense and finance costs | 0.0−55.2%0.1% | 0.0−12.2%— | 0.0−14.5%0.4% | 0.0−32.6%0.4% | 0.0+26.6%2.0% | 0.0+16.4%— | 0.0−95.2%17.1% | 0.4−71.2%0.7% | 1.5−36.5%2.2% | 2.3—5.1% | |
| Other non-operating income (expense) | 0.3+90.3%3.3% | 0.2—— | −7.2−293%−161% | 3.7r0.2+860%77.2% | 0.4—26.6% | −0.2−118%— | 1.2+4013%1001% | 0.0—0.0% | −1.1—−1.7% | −2.3—−5.1% | |
| Income before tax | — | — | — | −32—−664% | −36—−2465% | — | — | — | — | — | |
| Income tax | −8.4—−94.9% | −17—— | −30r0—−662% | −4.7r4.7—−96.3% | 0—0.0% | — | 0—0.0% | 0−100%0.0% | 0.1−83.5%0.1% | 0.5—1.1% | |
| Net income including minority interests | — | −17—— | −30—−662% | −28—−567% | −36—−2465% | — | — | — | — | — | |
| Net income attributable to shareholders | −8.4—−94.9% | −17—— | −30—−662% | −24r−28—−495% | −36—−2465% | −34—— | −22−163%−19007% | 36+44.8%59.3% | 25—36.8% | −13—−29.8% | |
| Earnings per share, basic | -2.96—— | -32.15—— | -2.02—— | -2.21—— | — | -0.14—— | -0.10−159%— | 0.17+41.7%— | 0.12—— | -0.07—— | |
| Earnings per share, diluted | -2.96—— | -32.15—— | -101.16—— | — | — | -0.14—— | -0.10−163%— | 0.16+33.3%— | 0.12—— | -0.07—— | |
| Shares, weighted average (basic) | 2.8+425%— | 0.5−96.3%— | 15+35.0%— | 11—— | — | — | 235+13.0%— | 208+4.8%— | 198+7.6%— | 184—— | |
| Shares, weighted average (diluted) | 2.8+425%— | 0.5+83.1%— | 0.3—— | — | — | 237+0.8%— | 235+8.1%— | 217+4.9%— | 207r207+12.5%— | 184—— | |
| Balance sheet | |||||||||||
| Cash and cash equivalents | 7.5+192%87.9% | 2.6−73.1%78.5% | 9.5−13.2%88.7% | 11−63.3%61.2% | 30−50.2%83.0% | 60−27.5%89.3% | 83+90.4%97.4% | 44+14.5%41.5% | 38−5.5%97.4% | 40—70.7% | |
| Short-term investments | — | — | 0−100%0.0% | 3.0—16.7% | 0—0.0% | — | — | — | — | — | |
| Receivables | 0.3—3.5% | 0—0.0% | 0−100%0.0% | 2.9+63.8%16.3% | 1.8+12.6%4.9% | 1.6—2.3% | 0−100%0.0% | 60—57.5% | 0−100%0.0% | 15—26.6% | |
| Inventory | — | — | 0−100%0.0% | 0.5−44.3%2.9% | 0.9−18.7%2.6% | 1.2—1.7% | 0—0.0% | — | — | — | |
| Other current assets | 0.4+14.1%4.4% | 0.3+34.4%10.0% | 0.2−87.2%2.3% | 1.9−1.8%10.6% | 1.9−36.8%5.4% | 3.1+314%4.5% | 0.7+15.8%0.9% | 0.6+24.1%0.6% | 0.5−49.2%1.3% | 1.0—1.8% | |
| Current assets | 8.2+180%95.8% | 2.9−70.1%89.4% | 9.8−40.1%90.9% | 16−52.8%91.0% | 35−47.5%95.9% | 66−21.2%97.9% | 84−19.9%98.3% | 104+171%99.7% | 39−31.9%98.7% | 57—99.6% | |
| Property, plant and equipment | 0.1−8.8%1.4% | 0.1−66.7%4.0% | 0.4−43.3%3.6% | 0.7+27.0%3.8% | 0.5+469%1.5% | 0.1−32.4%0.1% | 0.1−0.9%0.2% | 0.1−13.7%0.1% | 0.2−17.2%0.4% | 0.2—0.3% | |
| Right-of-use (leased) assets | 0.2+36.3%2.6% | 0.2−69.4%4.9% | 0.5−39.8%4.9% | 0.9−0.3%4.9% | 0.9−29.0%2.4% | 1.2−2.2%1.8% | 1.3—1.5% | 0—0.0% | — | — | |
| Total assets | 8.5+161%100% | 3.3−69.6%100% | 11−40.1%100% | 18−50.3%100% | 36−46.4%100% | 67−20.9%100% | 85−18.8%100% | 105+168%100% | 39−31.3%100% | 57—100% | |
| Accounts payable | 1.1−84.1%13.0% | 7.0+70.6%214% | 4.1−4.7%38.2% | 4.3+36.3%24.0% | 3.2+393%8.8% | 0.6−10.5%1.0% | 0.7+41.8%0.8% | 0.5−77.3%0.5% | 2.2+43.3%5.7% | 1.6—2.7% | |
| Current liabilities | 1.8−77.9%20.8% | 8.0−17.1%245% | 9.7−36.2%89.9% | 15−6.9%84.3% | 16+54.7%45.1% | 11+168%15.6% | 3.9−6.2%4.6% | 4.2−61.1%4.0% | 11−80.4%27.6% | 55—96.7% | |
| Long-term debt | — | — | — | — | — | — | — | 0.3r0−0.0%0.3% | 0.3−94.7%0.9% | 6.3—11.1% | |
| Lease liabilities (non-current) | 0.1+92.6%0.8% | 0.0−79.3%1.0% | 0.2−69.9%1.5% | 0.5+2.8%3.0% | 0.5−41.2%1.5% | 0.9−5.5%1.3% | 1.0—1.1% | 0—0.0% | — | — | |
| Total liabilities | 1.8−77.2%21.6% | 8.0−25.9%246% | 11−44.8%101% | 20r18−0.7%110% | 20+12.2%54.9% | 18+262%26.2% | 4.9+16.6%5.7% | 4.2−65.3%4.0% | 12−80.6%30.9% | 62—109% | |
| Retained earnings | −467—−5484% | −459—−14052% | −442—−4112% | −412r−416—−2297% | −388—−1076% | −352—−523% | −318—−374% | −296—−282% | −332—−851% | −357r−357—−628% | |
| Shareholders' equity | 6.7—78.4% | −4.8—−146% | −0.1—−1.0% | −2.0r0.1−112%−11.0% | 16−67.2%45.1% | 50−38.1%73.8% | 80−20.3%94.3% | 101+273%96.0% | 27—69.1% | −5.2—−9.1% | |
| Total liabilities and equity | 8.5+161%100% | 3.3−69.6%100% | 11−40.1%100% | 18−50.3%100% | 36−46.4%100% | 67−20.9%100% | 85−18.8%100% | 105+168%100% | 39−31.3%100% | 57—100% | |
| Shares outstanding | 1.8+91.4%— | 0.9+159%— | 0.4r18−96.9%— | 12+25.7%— | 9.3+0.7%— | 9.2r230−96.0%— | 229+1.1%— | 227+13.1%— | 201+24.9%— | 161—— | |
| Cash-flow statement | |||||||||||
| Depreciation and amortization | 0.1−75.8%0.7% | 0.3−23.6%— | 0.3+17.6%7.6% | 0.3+128%5.9% | 0.1+148%8.6% | 0.1−20.4%— | 0.1+9.5%54.4% | 0.1+3.7%0.1% | 0.1+71.2%0.1% | 0.0—0.1% | |
| Share-based compensation | 1.3−3.8%15.1% | 1.4−26.2%— | 1.9+11.8%41.7% | 1.7r1.4−33.2%34.5% | 2.5−20.9%171% | 3.2+1.0%— | 3.1−9.9%2660% | 3.5−1.0%5.8% | 3.5+100%5.2% | 1.8—3.9% | |
| Cash from operating activities | −14—−153% | −21—— | −31—−701% | −29r−28—−603% | −30r0.0—−2038% | −0.1r−23−100%— | 41—35026% | −22−1379%−36.1% | 1.7−86.8%2.5% | 13—28.8% | |
| Capital expenditure | −0.1—−0.6% | 0—— | −0.0—−0.9% | −0.4—−8.9% | −0.3—−17.8% | −0.0—— | −0.1—−53.3% | −0.0—−0.1% | −0.0—−0.0% | −0.1—−0.3% | |
| Cash from investing activities | −0.1−102%−0.6% | 3.1−74.9%— | 12—277% | −3.4—−70.6% | −0.3—−17.8% | −0.0—— | −0.1—−53.3% | −0.0−116%−0.1% | 0.2−77.1%0.3% | 1.0—2.2% | |
| Debt issued | — | — | — | — | — | — | — | — | 0—0.0% | 0—0.0% | |
| Shares issued | 17+112%192% | 8.0−45.7%— | 15+33.4%327% | 11r10—227% | 0—0.0% | — | — | — | — | — | |
| Cash from financing activities | 19+65.1%210% | 11−45.4%— | 21+91.2%458% | 11r9.9+58450%221% | 0.0r−30—1.3% | −23r−0.1—— | −1.9−107%−1629% | 27—45.3% | −4.1−123%−6.2% | 18—41.0% | |
| Change in cash | — | — | — | — | — | −23−158%— | 39+614%33344% | 5.5—9.1% | −2.2−107%−3.3% | 32—72.0% | |
| Report | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | |
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the same quarter a year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | Last 12 months4 quarters to Jun 30, 2026 | Q4 FY2026to Jun 30, 2026 | Q3 FY2026to Mar 31, 2026 | Q2 FY2026to Dec 31, 2025 | Q1 FY2026to Sep 30, 2025 | Q4 FY2025to Jun 30, 2025 | Q3 FY2025to Mar 31, 2025 | Q2 FY2025to Dec 31, 2024 | Q1 FY2025to Sep 30, 2024 | Q4 FY2024to Jun 30, 2024 | Q3 FY2024to Mar 31, 2024 | Q4 FY2023to Jun 30, 2023 | Q3 FY2023to Mar 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||||||
| Revenue | 13—100% | 0.3*—100% | 3.9—100% | 0.1—100% | 8.8r8.8—100% | 0*−100%— | 0—— | — | 0—— | 0.4*−80.1%100% | 0−100%— | 1.8*—100% | 1.2—100% | |
| Cost of revenue | — | — | — | — | — | — | — | — | — | 0*−100%0.0% | 0−100%— | 0.1*—5.9% | 0.1—10.8% | |
| Research and development | 12−17.0%93.9% | 2.0*+1.8%667% | 3.5−6.3%89.7% | 4.3+26.0%3723% | 2.5−56.0%28.6% | 2.0*−57.8%— | 3.8−47.6%— | 3.4—— | 5.7—— | 4.7*−36.9%1335% | 7.2+48.2%— | 7.4*—420% | 4.8—404% | |
| Selling, general and administrative | — | — | — | — | 1.7−17.8%18.8% | 2.6*−34.2%— | 1.5−27.5%— | 1.7—— | 2.0—— | 4.0*−21.0%1144% | 2.0−42.5%— | 5.1*—288% | 3.5—296% | |
| General and administrative | — | 2.7*+3.1%903% | 2.0+34.6%50.6% | 3.1+85.8%2693% | — | 2.6*—— | 1.5—— | 1.7—— | — | — | — | — | 3.5—296% | |
| Operating expenses | 22+25.2%166% | 4.7*+108%1569% | 5.5+14.3%140% | 7.4+185%6416% | 4.2−46.1%47.4% | 2.3*−73.9%— | 4.8−47.8%— | 2.6—— | 7.8—— | 8.7*−30.9%2483% | 9.2+8.5%— | 13*—714% | 8.5—711% | |
| Total costs and expenses | — | — | — | — | — | 0*—— | 0*—— | 0*—— | 9.2—— | 0*—0.0% | — | 0*—0.0% | 0*—0.0% | |
| Operating income | −8.7—−65.8% | −4.4*—−1469% | −1.6—−40.3% | −7.3—−6316% | 4.7—52.8% | −2.3*—— | −4.8—— | −2.6—— | −7.8—— | −8.3*—−2383% | −9.2—— | −11*—−614% | −7.3—−611% | |
| Interest expense and finance costs | 0.0−55.2%0.1% | 0.0*−15.2%1.0% | 0.0−29.4%0.0% | 0.0−86.9%0.4% | 0.0−66.3%0.0% | 0.0*+3.4%— | 0.0+43.1%— | 0.0—— | 0.0—— | 0.0*+126%1.0% | 0.0−63.5%— | 0.0*—0.1% | 0.0—0.3% | |
| Other non-operating income (expense) | 0.3+90.3%2.2% | 0.1*+49.5%20.4% | 0.1+8324%3.8% | 0.1−61.7%55.7% | 0.0—0.2% | 0.0*−55.3%— | 0.0−99.8%— | 0.2—— | −0.1—— | 0.1*−90.8%26.2% | 0.8—— | 1.0r0.1*—56.7% | −1.4r0.2—−114% | |
| Income before tax | — | — | — | — | — | — | — | — | — | — | — | −11*—−608% | −7.1—−598% | |
| Income tax | — | — | — | — | — | — | — | — | — | −30r0*—−8496% | 0—— | −9.3r9.3*—−531% | 0—0.0% | |
| Net income including minority interests | — | — | — | — | 4.7—53.0% | −2.2*—— | −4.8*—— | −2.4*—— | −7.8—— | −8.3*—−2357% | — | −44*—−2518% | 7.1*—598% | |
| Net income attributable to shareholders | −8.4—−63.6% | −4.4*—−1449% | −1.4—−36.5% | −7.3—−6260% | 4.7—53.0% | −2.2*—— | −4.8—— | −2.4—— | −7.8—— | −8.3*—−2357% | −8.4—— | −9.8r−11*—−557% | −8.7r−7.1—−725% | |
| Earnings per share, basic | — | — | -0.37—— | -2.86—— | 4.81—— | — | -9.13—— | -5.92r-0.12—— | -19.71r-0.39—— | — | — | — | — | |
| Earnings per share, diluted | — | — | -0.37—— | -2.86—— | 4.26—— | — | -9.13r-0.18—— | -5.92—— | -19.71—— | — | -0.53—— | — | — | |
| Shares, weighted average (basic) | — | — | 3.9+642%— | 2.5+515%— | 1.0+145%— | — | 0.5—— | 0.4r21—— | 0.4r20—— | — | — | — | — | |
| Shares, weighted average (diluted) | — | — | 3.9+642%— | 2.5+515%— | 1.1+177%— | — | 0.5r26−96.7%— | 0.4—— | 0.4—— | — | 16—— | — | — | |
| Balance sheet | ||||||||||||||
| Cash and cash equivalents | 7.5—87.9% | 7.5+192%87.9% | 10+303%76.8% | 14+324%80.7% | 1.3−46.6%14.8% | 2.6−73.1%78.5% | 2.5−88.3%67.6% | 3.4—79.3% | 2.4—69.8% | 9.5−13.2%88.7% | 21+9.4%188% | 11—61.2% | 20—76.7% | |
| Short-term investments | — | — | — | — | — | — | — | — | — | 0−100%0.0% | 0—0.0% | 3.0—16.7% | — | |
| Receivables | 0.3—3.5% | 0.3—3.5% | — | 1.6—9.1% | 6.9—79.9% | 0—0.0% | — | — | — | 0−100%0.0% | 0−100%0.0% | 2.9—16.3% | 1.7—6.6% | |
| Inventory | — | — | — | — | — | — | — | — | — | 0−100%0.0% | 0−100%0.0% | 0.5—2.9% | 0.6—2.5% | |
| Other current assets | 0.4—4.4% | 0.4+14.1%4.4% | 0.5+3.7%3.5% | 1.4+435%7.6% | 0.2−16.6%2.2% | 0.3+34.4%10.0% | 0.4+73.7%11.9% | 0.3—5.9% | 0.2—6.7% | 0.2−87.2%2.3% | 0.3−88.8%2.2% | 1.9—10.6% | 2.3—8.9% | |
| Current assets | 8.2—95.8% | 8.2+180%95.8% | 13+295%96.7% | 17+376%97.4% | 8.4+220%97.2% | 2.9−70.1%89.4% | 3.2−68.5%86.7% | 3.7—85.1% | 2.6—76.5% | 9.8−40.1%90.9% | 10−57.6%90.0% | 16—91.0% | 24—94.7% | |
| Property, plant and equipment | 0.1—1.4% | 0.1−8.8%1.4% | 0.1−26.0%1.0% | 0.1−51.9%0.6% | 0.1−62.6%1.3% | 0.1−66.7%4.0% | 0.2−60.8%4.9% | 0.2—5.5% | 0.3—9.0% | 0.4−43.3%3.6% | 0.5−34.8%4.1% | 0.7—3.8% | 0.7—2.8% | |
| Right-of-use (leased) assets | 0.2—2.6% | 0.2+36.3%2.6% | 0.3+10.8%2.1% | 0.3−0.3%1.9% | 0.1−70.4%1.5% | 0.2−69.4%4.9% | 0.3−58.4%6.9% | 0.3—8.1% | 0.4—12.8% | 0.5−39.8%4.9% | 0.6+2.6%5.4% | 0.9—4.9% | 0.6—2.3% | |
| Total assets | 8.5—100% | 8.5+161%100% | 13+255%100% | 18+316%100% | 8.6+152%100% | 3.3−69.6%100% | 3.7−67.3%100% | 4.3—100% | 3.4—100% | 11−40.1%100% | 11−55.5%100% | 18—100% | 26—100% | |
| Accounts payable | 1.1—13.0% | 1.1−84.1%13.0% | 1.7−78.2%12.8% | 5.5−18.8%30.4% | 7.4+87.5%86.0% | 7.0+70.6%214% | 7.8+126%208% | 6.7—156% | 3.9—116% | 4.1−4.7%38.2% | 3.4+23.6%30.2% | 4.3—24.0% | 2.8—10.9% | |
| Current liabilities | 1.8—20.8% | 1.8−77.9%20.8% | 2.5−74.8%19.2% | 6.3−33.8%35.3% | 8.2−16.7%95.4% | 8.0−17.1%245% | 10+17.8%270% | 9.6—222% | 9.9—289% | 9.7−36.2%89.9% | 8.5−28.0%74.8% | 15—84.3% | 12—46.3% | |
| Lease liabilities (non-current) | 0.1—0.8% | 0.1+92.6%0.8% | 0.1+44.9%0.7% | 0.1+29.0%0.7% | 0−100%0.0% | 0.0−79.3%1.0% | 0.1−74.4%1.8% | 0.1—2.3% | 0.1—3.9% | 0.2−69.9%1.5% | 0.3−18.2%2.3% | 0.5—3.0% | 0.3—1.3% | |
| Total liabilities | 1.8—21.6% | 1.8−77.2%21.6% | 2.6−74.0%19.9% | 6.5−39.6%36.0% | 8.2−26.0%95.4% | 8.0−25.9%246% | 10+2.9%271% | 11—248% | 11—325% | 11−44.8%101% | 9.8−38.6%86.2% | 20r18—110% | 16—62.5% | |
| Retained earnings | −467—−5484% | −467—−5484% | −463—−3502% | −462—−2575% | −454—−5275% | −459—−14052% | −457—−12253% | −452—−10488% | −450—−13164% | −442—−4112% | −434—−3801% | −412r−416—−2297% | −405—−1581% | |
| Shareholders' equity | 6.7—78.4% | 6.7—78.4% | 11—80.1% | 11—64.0% | 0.4—4.6% | −4.8—−146% | −6.4−505%−171% | −6.4—−148% | −7.7—−225% | −0.1—−1.0% | 1.6−76.0%13.8% | −2.0r0.1—−11.0% | 6.6r9.6—25.7% | |
| Total liabilities and equity | 8.5—100% | 8.5+161%100% | 13+255%100% | 18+316%100% | 8.6+152%100% | 3.3−69.6%100% | 3.7−67.3%100% | 4.3—100% | 3.4—100% | 11−40.1%100% | 11−55.5%100% | 18—100% | 26—100% | |
| Shares outstanding | 1.8—— | 1.8+91.4%— | 1.8−93.8%— | 1.8−92.5%— | 1.0−95.0%— | 0.9+159%— | 29+77.0%— | 23—— | 20—— | 0.4r18−96.9%— | 16+44.7%— | 12—— | 11—— | |
| Cash-flow statement | ||||||||||||||
| Depreciation and amortization | 0.1−75.8%0.5% | 0.0*−68.0%5.6% | 0.0*−68.2%0.4% | 0.0*−80.0%12.4% | 0.0−82.2%0.2% | 0.1*−35.3%— | 0.1*—— | 0.1*—— | 0.1—— | 0.1*+1.1%23.4% | — | 0.1*—4.6% | 0.1*—6.5% | |
| Share-based compensation | 1.3−3.8%10.1% | 0.4*+27.9%143% | 0.4*+20.8%10.7% | 0.3*−11.0%268% | 0.2−51.9%1.9% | 0.3*−37.9%— | 0.3*—— | 0.3—— | 0.3—— | 0.5*+144%155% | — | 0.2*—12.6% | 0.4—33.2% | |
| Cash from operating activities | −14—−103% | −2.7*—−894% | −4.4*—−113% | −4.8*—−4143% | −1.6—−18.3% | −4.1*—— | −5.4*—— | −4.8*—— | −7.0—— | −6.5*—−1849% | — | −9.6r−9.6*—−545% | −1.4r−1.4*—−118% | |
| Capital expenditure | — | 0*—0.0% | −0.0*—−1.0% | — | — | 0*—— | 0*—— | — | — | −0.0*—−1.4% | — | −0.1*—−3.0% | −0.1*—−9.8% | |
| Cash from investing activities | — | 0*−100%0.0% | −0.0*—−1.0% | — | — | 0.6*—— | 0*—— | 2.5*—— | 0—— | −0.0*—−1.4% | — | −3.0*—−173% | −0.1*—−9.8% | |
| Shares issued | — | 0*−100%0.0% | −0.0*−100%−0.0% | — | — | 3.5*—— | 4.5*—— | 0*—— | 0—— | −0.0*−103%−7.9% | — | 1.0r1.0*—58.7% | 0r−0.9*—0.0% | |
| Cash from financing activities | 19+65.1%141% | 0.0*−99.4%7.5% | 0.1*−96.9%3.5% | 18*+433%15532% | 0.3—3.7% | 3.5*−41.5%— | 4.5*—— | 3.4*—— | −0.1—— | 6.0*+494%1712% | — | 1.0r1.0*—57.2% | −0.0r−0.0*—−2.1% | |
| Report | Worked out | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-K | 10-Q | |
* Worked out from reported figures: a quarter the company states only within a year-to-date figure (cash flows are reported that way), or the fourth quarter as the fiscal year minus the first nine months.
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.
Source: SEC EDGAR filings (XBRL) · as of Jun 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative
Where Palatin Technologies, Inc. operates: 2 countries#
Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue. 1 subsidiaries on file.
Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided
Executive pay at Palatin Technologies, Inc.#
From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.
| Fiscal year | CEO total pay | Actually paid | Other executives, average | $100 invested |
|---|---|---|---|---|
| 2025Carl Spana | $739 K | $96 K | $688 K | $2 |
| 2024Carl Spana | $1.4 M | $661 K | $1.4 M | $29 |
| 2023Carl Spana | $1.3 M | $284 K | $1.2 M | $31 |
Source: SEC proxy statement (Form DEF 14A) · as of Jun 30, 2025
Events at Palatin Technologies, Inc.#
What the company reported to the SEC within four business days (Form 8-K), newest first.
Warning signs in the last three years
Delisting notice 5 · Material agreement 7 · Unregistered share sale 3 · Shareholder rights changed 1 · Bylaws or fiscal year changed 2 · Shareholder vote 3 · Results announced 1
| Filed | What happened | Filing |
|---|---|---|
| Shareholder vote | 8-K | |
| Delisting notice | 8-K | |
| Shareholder vote | 8-K/A | |
| Material agreement | 8-K | |
| Material agreement | 8-K | |
| Shareholder rights changedBylaws or fiscal year changed | 8-K | |
| Shareholder vote | 8-K | |
| Delisting notice | 8-K | |
| Material agreementUnregistered share saleBylaws or fiscal year changed | 8-K | |
| Delisting noticeMaterial agreement | 8-K | |
| Delisting notice | 8-K | |
| Material agreement | 8-K | |
| Material agreementUnregistered share sale | 8-K | |
| Material agreementUnregistered share sale | 8-K | |
| Results announced | 8-K | |
| Delisting notice | 8-K |
Source: SEC EDGAR, Form 8-K item numbers · as of Aug 3, 2026
Acquisitions and funding#
Private share sales · funding history
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Jul 2012 | $35 M | Private placement after listing | $10 to $50 million | 3 | equity, options | SEC |
Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.
H-1B hiring at Palatin Technologies, Inc.#
1 labor condition applications certified in fiscal 2026 for 1 positions, at a median wage of $97 K a year.
| Job title | Positions | Median wage offered |
|---|---|---|
| Quality Assurance ManagerIndustrial Engineers | 1 | $97 K |
Where: Monmouth Junction, NJ 1
| Fiscal year | Certified | Positions | Median wage | Filed |
|---|---|---|---|---|
| FY2026 | 1 | 1 | $97 K | 1 |
| FY2023 | 1 | 1 | $112 K | 1 |
| FY2022 | 1 | 1 | $90 K | 1 |
Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as Palatin Technologies, Inc.
From US state WARN notices and SEC 8-K restructuring filings, newest first.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2010 | · | · | · | · | · | · | · | · | · | · | · | · | — |
| 2008 | · | · | · | · | · | · | · | · | · | · | · | · | — |
| 2007 | · | · | · | · | · | · | · | · | · | · | · | · | — |
| Announced | People | Kind | Where | Source |
|---|---|---|---|---|
| 50% of workforce | Restructuring planSEC 8-K | “In implementing this plan, Palatin is reducing its workforce by approximately 50% and discontinuing research activities relating to the discovery of new compounds.” | Filing | |
| 30% of workforce | Restructuring planSEC 8-K | “Continuing its melanocortin receptor-based collaboration with AstraZeneca AB on developing compounds for treating obesity; and • Effecting an immediate reduction in force of 30% of…” | Filing | |
| 30% of workforce | Restructuring planSEC 8-K | “PTN) (the Company) today announced it has taken steps to reduce its workforce by 30%, resulting in annual savings of $4 million.” | Filing |
Source: State WARN notices and SEC 8-K item 2.05
How Palatin Technologies, Inc. compares in Biotechnology
- Market cap$9 M · higher than 9% of 726
- Revenue$9 M · higher than 42% of 647
- Net margin-94.9% · higher than 42% of 408
- Price / sales1.0× · lower than 93% of 339
- Price / book1.3× · lower than 71% of 534
- FCF yield-154.7% · higher than 4% of 449
Peer comparison · Biotechnology
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Palatin Technologies, Inc.🇺🇸 | $9 M | — | -94.9% | — |
| Novo Nordisk A/S🇩🇰 | $203.2 B | 13.1× | 33.1% | +10.8% |
| Vertex Pharmaceuticals Incorporated🇺🇸 | $134.3 B | 33.8× | 30.7% | +8.9% |
| Moderna, Inc.🇺🇸 | $90.1 B | — | -110.5% | -39.9% |
| Regeneron Pharmaceuticals, Inc.🇺🇸 | $84.1 B | 17.5× | 28.5% | +1.0% |
| Argenx SE🇳🇱 | $52.8 B | 40.9× | 31.1% | +89.9% |
| CSL Limited🇦🇺 | $51.6 B | — | -16.4% | — |
| Samsung Biologics Co., Ltd.🇰🇷 | $51.5 B | 40.5× | 39.2% | — |
| UCB SA🇧🇪 | $48.6 B | 26.3× | 20.1% | +31.1% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Regenxbio Inc.$513 M
- Pharmicell Co., Ltd.$514 M
- Pulike Biological Engineering, Inc.$524 M
- Contineum Therapeutics, Inc.$534 M
- Entera Bio Ltd.$543 M
- Arvinas, Inc.$544 M
Sources and freshness
- Market cap:
- Oct 30, 2026
- Annual results:
- For year ending June-2026
- Balance sheet:
- As of June-2026
- Employees:
- As of September 25, 2026
- Profile updated:
- Nov 20, 2026
Figures from Market data, SEC filing, value.today research, SEC annual report, GLEIF register; financial statements from SEC filings.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Palatin Technologies, Inc.? Verify and update this profile — free
Show Palatin Technologies, Inc.'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.